Viking offers asymmetric upside in GLP-1 drugs with positive trial data, strong cash, and buyout potential despite biotech ...

GDP growth won’t make India a developed country. The asking rate is 12-plus now A surplus monsoon bodes well for agriculture and rural demand this year. GST reforms, which kicked in 10 days ...